Land, V J <br/><br/>
Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 1994 
 - 1939-45 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1994.12.9.1939  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Central Nervous System Diseases--chemically induced<br/>Child<br/>Child, Preschool<br/>Cytarabine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Methotrexate--administration & dosage<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Remission Induction<br/>Risk Factors<br/>United States